Literature DB >> 13130412

Severe bacterial infection in transfusion-dependent patients with thalassemia major.

Shih-Chung Wang1, Kai-Hsin Lin, Jimmy P S Chern, Meng-Yao Lu, Shiann-Tarng Jou, Dong-Tsamn Lin, Kuo-Sin Lin.   

Abstract

The incidence and clinical spectrum of severe bacterial infection were studied in 89 patients with thalassemia major that was diagnosed between January 1971 and March 2002. There were 20 patients with 24 episodes of severe bacterial infection, resulting in an incidence of 1.6 infections per 100 patient-years. The clinical spectrum included liver abscess (6 cases), septicemia (6 cases), soft-tissue infection (2 cases), osteomyelitis (2 cases), corneal ulcer (1 case), enteritis (1 case), and abscesses of the lung, kidney, intra-abdominal region, retropharynx, gums, and buttocks (1 case each). The leading causal microorganisms were gram-negative bacilli, especially Klebsiella pneumoniae (10 of 20 isolates). Other responsible pathogens were Pseudomonas aeruginosa (2/20), Vibrio vulnificus (2/20), Acinetobacter baumanii (1/20), Streptococcus intermidius (1/20), Yersinia enterocolitica (1/20), Staphylococcus aureus (1/20), Escherichia coli (1/20), and Salmonella species (1/20). Splenectomy and delays in the start of iron-chelating therapy were 2 independent risk factors.

Entities:  

Mesh:

Year:  2003        PMID: 13130412     DOI: 10.1086/378062

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  Characterization of circulating CD4+ CD8+ double positive and CD4- CD8- double negative T-lymphocyte in children with β-thalassemia major.

Authors:  Asmaa M Zahran; Khaled Saad; Khalid I Elsayh; Mohamd A Alblihed
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

2.  Iron: a double-edged sword.

Authors:  Lyla A Youssef; Steven L Spitalnik
Journal:  Transfusion       Date:  2017-10       Impact factor: 3.157

3.  Hand-assisted laparoscopic surgery with a Pfannenstiel incision in beta-thalassemia patients: initial experience.

Authors:  Emmanuel Leandros; Nicholas Alexakis; Konstadinos Albanopoulos; Dimitris Dardamanis; Markisia Karagiorga; Ilias Gomatos; Stefanos Papadopoulos; Christos Bacoyiannis; John Bramis
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

4.  Clinical spectrum of serious bacterial infections among splenectomized patients with hemoglobinopathies in Israel: a 37-year follow-up study.

Authors:  W Sakran; C Levin; Y Kenes; R Colodner; A Koren
Journal:  Infection       Date:  2011-08-25       Impact factor: 3.553

Review 5.  Innate Nutritional Immunity.

Authors:  Gabriel Núñez; Kei Sakamoto; Miguel P Soares
Journal:  J Immunol       Date:  2018-07-01       Impact factor: 5.422

Review 6.  Molecular and clinical aspects of iron homeostasis: From anemia to hemochromatosis.

Authors:  Manfred Nairz; Günter Weiss
Journal:  Wien Klin Wochenschr       Date:  2006-08       Impact factor: 1.704

Review 7.  Iron homeostasis in host defence and inflammation.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Nat Rev Immunol       Date:  2015-07-10       Impact factor: 53.106

8.  Up-regulation of NKG2A inhibitory receptor on circulating NK cells contributes to transfusion-induced immunodepression in patients with β-thalassemia major.

Authors:  Yong Zou; Zhi-Xing Song; Ying Lu; Xiao-Li Liang; Qing Yuan; Si-Hong Liao; Jun-Jie Bao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

9.  Slc11a1 limits intracellular growth of Salmonella enterica sv. Typhimurium by promoting macrophage immune effector functions and impairing bacterial iron acquisition.

Authors:  Manfred Nairz; Gernot Fritsche; Marie-Laure V Crouch; Howard C Barton; Ferric C Fang; Günter Weiss
Journal:  Cell Microbiol       Date:  2009-06-02       Impact factor: 3.715

Review 10.  Nutritional immunity: transition metals at the pathogen-host interface.

Authors:  M Indriati Hood; Eric P Skaar
Journal:  Nat Rev Microbiol       Date:  2012-07-16       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.